Cytomegalovirus immunoglobulin G titers do not predict reactivation risk in immunocompetent hosts

Area of Science:

• Virology
• Immunology
• Critical Care Medicine

Background:

• Cytomegalovirus (CMV) reactivation affects a third of immunocompetent patients during critical illness, linked to adverse outcomes.
• Early antiviral prophylaxis is considered, but risks overtreatment in two-thirds of patients.
• Tissue viral load and immune responses to CMV are potential predictors of reactivation.

Purpose of the Study:

• To investigate the correlation between serum CMV-specific IgG and tissue viral load.
• To determine if serum CMV-specific IgG can predict CMV reactivation risk in critical illness.

Main Methods:

• Laboratory infection of inbred mice to assess tissue viral load and serum CMV-specific IgG.
• Analysis of naturally infected outbred hosts (mice and humans) for tissue viral DNA loads and serum IgG.
• Evaluation of CMV-specific IgG levels in relation to reactivation events and viral DNAemia in immunocompetent humans.

Main Results:

• A strong correlation between tissue viral load and serum CMV-specific IgG was observed in laboratory-infected mice.
• Naturally infected outbred hosts showed variable tissue viral loads that did not correlate well with serum IgG.
• CMV-specific IgG levels did not predict reactivation events in immunocompetent humans; lower IgG correlated with longer reactivation duration but not peak viral DNAemia.

Conclusions:

• Serum CMV-specific IgG titers diverge from tissue viral loads in outbred immunocompetent hosts.
• The predictive value of CMV-specific IgG for reactivation risk and its role in controlling reactivation events remain uncertain in humans.
• Current findings question the utility of serum CMV-specific IgG for guiding antiviral prophylaxis decisions in critically ill patients.